Form 4 for ADIL ADIAL PHARMACEUTICALS, INC.
Accepted 2021-11-30 00:00:00 ET · period of report 2021-11-26 · accession 0001213900-21-062465 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-11-30 | 2021-11-26 | ADIL | Newman James W. Jr. | Dir | P - Purchase | $2.85 | +10.0K | 34.5K | +41% | +$28.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-26 | P | A | 10,000 | $2.85 | 34,475 | I Rountop Limited Partnership, LLP | — | — | (F1) James W. Newman, Jr. is the general partner of Roundtop Limited Partnership, LLP. |